Clinical Trial Update: Study of Focal Cryoablation in Low-Risk Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating focal cryoablation for low-risk prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED